Celon Laboratories Ltd
Albumin (20% w/v)
Albuone 20% Injection is used to treat blood volume loss by replacing body fluids lost due to trauma, bleeding, surgery, or kidney dialysis.
Injection
Albuone 20% Injection must be administered under the supervision of a healthcare professional. You should not take it if you have any known allergies to this injection. Before taking it, inform the doctor if you are suffering from any severe heart disease. Your doctor may check your blood pressure and ask you to get regular blood tests done while you are using this injection. The most common side effects include flushing, nausea, vomiting, chills, and fever. Inform your doctor if you are pregnant or breastfeeding. Let your doctor also know if you have any kidney diseases as a dose adjustment may be required. This injection is safe to use in patients suffering from liver diseases.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Albuone 20% Injection contains human albumin, a natural protein in blood. It works by replacing the blood or body fluids lost due to excessive bleeding, surgery, or kidney dialysis.
It is given as an injection into veins under the supervision of a medical professional. Inform your doctor immediately if you experience a skin rash, itching, breathing difficulties, swelling of face, and changes in heartbeat while using this medicine. Inform your doctor if you have a history of severe anemia (lack of red blood cells) or severe heart failure.
Before you receive this medicine, you must inform your doctor if you are allergic to albumin preparations or any of the other ingredients in this medication. Suspicion of allergic or anaphylactic reactions requires immediate cessation of the infusion.
Before administering this injection, your doctor or nurse will measure your blood pressure, heart rate, and perform blood tests to ensure a safe dosage. If you experience any headache, difficulty breathing, or an increase in blood pressure, please inform your doctor immediately.
This medication must be given intravenously at a rate not exceeding 1 mL/min to patients with normal blood volume. This is to minimize the risk of developing circulatory overload and pulmonary edema (excess fluid in the lungs).